Nordic Nanovector appoints Dr Reza Safaei as head of Medical Affairs
Nordic Nanovector and Heidelberg Pharma collaborate to develop novel ADCs targeting leukaemias
Nordic Nanovector and LegoChem Biosciences collaborate to develop novel antibody-drug conjugates (ADCs) targeting leukaemias
Betalutin publications highlight benefits of predosing regimen
